MedPath

to compare dexmedetomidine and propofol for sedation during simple operative procedures.

Phase 2
Conditions
Health Condition 1: null- patients with impaired liver function
Registration Number
CTRI/2015/01/005465
Lead Sponsor
IDA NAWAZ
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

•Patients undergoing elective ERCP with impaired liver function (i.e. raised serum bilirubin ,SGOT or SGPT levels)

•Normal prothrombin time (PT) and international normalized ratio (INR)

•ASA grade II.

• Aged between 18 and 60 years.

•Those who are willing to give written informed consent

Exclusion Criteria

•ASA grade III or more.

•Patients with comorbid conditions such as HTN, DM or renal insufficiency.

•Patients having difficulty in communication (due to language problem or deafness).

•Patients with history of operative intervention in the past 72 hrs.

•Patients with the known allergy to these drugs and with a history of sulphite ,egg or soyabean allergy

•Pregnant patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath